It is the first such approval for the UK but the technique has already previously been used: a baby was born in Mexico in 2016 using the experimental therapy.
The treatment fixes problems linked to mitochondria, the energy-producing structures outside a cell's nucleus.
Faulty mitochondria can result in conditions including muscular dystrophy and major organ failure. The technique uses DNA from two women and one man.
Disclaimer: No Business Standard Journalist was involved in creation of this content